Fortress Biotech (FBIO) Cash from Investing Activities Growth (1y) (2014 - 2024)
Powered by 
Analysis
Fortress Biotech (FBIO) Cash from Investing Activities Growth (1y) (2014 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 90.55% |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 91.53% |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | -41.67% |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 25.90% |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | -157.08% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 26.37% |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | -89.24% |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -23,709.52% |
| Dec 31, 2023 | 83.89% |
| Sep 30, 2023 | 659.80% |
| Jun 30, 2023 | -564.17% |
| Mar 31, 2023 | 76.57% |
| Dec 31, 2022 | -100.73% |
| Sep 30, 2022 | 88.16% |
| Jun 30, 2022 | 93.66% |
| Mar 31, 2022 | -4,558.73% |
| Dec 31, 2021 | 3,504.79% |
| Sep 30, 2021 | -173.42% |
| Jun 30, 2021 | -355.32% |
| Mar 31, 2021 | 74.21% |
| Dec 31, 2020 | -605.48% |
| Sep 30, 2020 | 26.45% |
| Jun 30, 2020 | -73.98% |
| Mar 31, 2020 | -107.35% |
| Dec 31, 2019 | -97.71% |
| Sep 30, 2019 | -140.19% |
| Jun 30, 2019 | 72.09% |